News of Note—Anthem will cover artificial pancreas; Takeda posts update on depression-monitoring smartwatch study

newspaper

> Anthem, the second-largest insurance company nationwide, will cover artificial pancreas systems. Drug Delivery Business News story

> Takeda and Cognition Kit reported strong compliance in 30-person trial investigating the use of the Apple Watch to monitor people with major depressive disorder. Release | Read more from FierceMedTech

> The FDA cleared Kaléo’s AUVI-Q 0.1 mg Auto-injector, the first and only epinephrine autoinjector designed to treat allergic reactions in infants and small children. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

As GlaxoSmithKline looks to start a 23andMe-partnered test this year, the Big Pharma is increasingly looking to tech for its R&D.

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its "Star Trek"-inspired digital X-ray bed.